Soluble vascular endothelial growth factor receptor 2 and prognosis in patients with chronic heart failure

Soluble vascular endothelial growth factor receptor 2 and prognosis in patients with chronic heart failure

Abstract Aims Endothelial cell vascular endothelial growth factor receptor 2 (VEGFR‐2) plays a pivotal role in angiogenesis, which induces physiological cardiomyocyte hypertrophy via paracrine signalling between endothelial cells and cardiomyocytes. We investigated whether a decrease in circulating...

Full description

Bibliographic Details
Main Authors: Moritake Iguchi, Hiromichi Wada, Tsuyoshi Shinozaki, Masahiro Suzuki, Yoichi Ajiro, Morihiro Matsuda, Akihiro Koike, Tomomi Koizumi, Masatoshi Shimizu, Yujiro Ono, Takashi Takenaka, Satoru Sakagami, Yukiko Morita, Kazuteru Fujimoto, Kazuya Yonezawa, Kazuro Yoshida, Akiyo Ninomiya, Toshihiro Nakamura, Junichi Funada, Yutaka Kajikawa, Yoshifumi Oishi, Toru Kato, Kazuhiko Kotani, Mitsuru Abe, Masaharu Akao, Koji Hasegawa, for the PREHOSP‐CHF Study Investigators
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:ESC Heart Failure
Subjects:
Heart failure
Biomarker
Angiogenesis
Lymphangiogenesis
Mortality
Online Access:https://doi.org/10.1002/ehf2.13555

Internet

https://doi.org/10.1002/ehf2.13555

Similar Items